Sheena Jonathan sold $995K of NTRA
Sheena Jonathan sold 3,150 shares of Natera, Inc. (NTRA) at an average of $316.00 ($304.57–$325.05, $1.00M total) across 19 trades on 2026-11-06 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The sale represents a modest insider divestment, which may cause short‑term price pressure but is unlikely to affect long‑term valuation.
Market read
Primary relevance is the insider sale; broader market impact is limited.
What to watch
No new corporate developments accompany the sale; the transaction size is modest relative to NTRA's market cap.
Background
SEC Form 4 filings disclose insider transactions. This filing reports a director's open‑market sale of 3,150 shares at an average price of $316.00.
Ticker impact
Director Sheena Jonathan sold $995K of Natera shares via a Form 4 filing on 2026-11-06.
likely pressure as the market prices in the insider sell
A $1M‑scale insider sale by a director is a material but modest signal; investors may view it as a slight negative.
Market effects
Minimal impact on the broader biotech sector; insider sales are common and rarely move the sector.
Limited to U.S. markets where NTRA trades.
Low global relevance.
Counterpoint
The sale could be unrelated to fundamentals; the director may be diversifying without negative implications for the company.
Key entities
- companyNatera, Inc.
US‑listed biotech company (NASDAQ: NTRA).
- personSheena Jonathan
Director of Natera who sold shares.



